D.A. Davidson & CO. Buys 8,983 Shares of The Allstate Co. (NYSE:ALL)

D.A. Davidson & CO. grew its holdings in shares of The Allstate Co. (NYSE:ALL) by 61.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,584 shares of the insurance provider’s stock after buying an additional 8,983 shares during the period. D.A. Davidson & CO.’s holdings in Allstate were worth $4,473,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of ALL. Northwest Investment Counselors LLC bought a new stake in shares of Allstate during the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC bought a new stake in shares of Allstate during the 3rd quarter valued at $29,000. Versant Capital Management Inc boosted its holdings in shares of Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. bought a new stake in shares of Allstate during the 2nd quarter valued at $38,000. Finally, MCF Advisors LLC boosted its holdings in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after buying an additional 84 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Allstate Trading Up 0.2 %

Allstate stock opened at $208.20 on Friday. The firm has a 50 day moving average of $192.69 and a 200 day moving average of $178.77. The firm has a market capitalization of $55.13 billion, a price-to-earnings ratio of 13.48, a P/E/G ratio of 1.80 and a beta of 0.48. The Allstate Co. has a 12-month low of $134.17 and a 12-month high of $209.88. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43.

Allstate (NYSE:ALL) last released its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The firm’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.81 EPS. As a group, research analysts predict that The Allstate Co. will post 16.07 earnings per share for the current year.

Allstate Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be issued a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 1.77%. The ex-dividend date is Friday, November 29th. Allstate’s dividend payout ratio is 23.83%.

Insider Buying and Selling

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.80% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. JPMorgan Chase & Co. lifted their price target on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. TD Cowen lifted their price target on Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd. BMO Capital Markets lifted their price target on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Jefferies Financial Group lifted their price target on Allstate from $231.00 to $267.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, Keefe, Bruyette & Woods lifted their price target on Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $217.19.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.